|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 22 • Issue 44 • October 31, 2019
|
|
|
German researchers reported, "All patients reported an improvement of myotonia, especially in weeks three and four of treatment."
|
|
|
|
|
|
Greg Ibach, USDA Under Secretary for Marketing and Regulatory Programs, said that the agency will "use the 2020 growing season to test drive the interim rule to guide any adjustments made in the final rule."
|
|
|
|
|
|
Forty percent of subjects tested positive for the presence of carboxy-THC in urine for time periods exceeding 25 days.
|
|
|
|
Fifty-eight percent of respondents agreed with the statement that "medical cannabis was a legitimate medical therapy."
|
|
|
|
|
|
Investigators concluded: "Our findings support the notion that MC (medical cannabis) may have an important role... in treating a number of common symptoms experienced by individuals living with SCI."
|
|
|
|
A specific cause of the illness remains unknown, though some experts have speculated that the injuries may be related to additive ingredients in the e-liquid products, such as Vitamin E oil, or the presence of a specific metal-binding agent in certain types of portable cartridges.
|
|
|
|
|
|
No One Wants to Give Your Kids Free Edibles Details
10/31/19 3:10pm UTC
Nevada NORML’s Veteran’s Virtual Lobby Day Details
10/30/19 6:35pm UTC
USDA Issues Hemp Regulations Details
10/29/19 9:40pm UTC
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|